News
Media
Conferences
Publications
Events
CME/CE
Resources
Career Center
Subscribe

Your AI-Trained Oncology Knowledge Connection!

Ian C. Anderson

Articles by Ian C. Anderson

37 Open-Label, Phase 2, Multicenter Study of Lasofoxifene (LAS) Combined With Abemaciclib (Abema) for Treating Pre- and Postmenopausal Women With Locally Advanced or Metastatic ER+/HER2− Breast Cancer and an ESR1 Mutation After Progression on Prior Therapies

ByDavid J. Portman,Senthil Damodaran,Paul V. Plourde,Halle C. F. Moore, MD,Ian C. Anderson

April 27th 2023

Latest Updated Articles

Trending on CancerNetwork

Blood-Based Screening Test May Increase Preclinical Lung Cancer Detection

FDA OKs Pembrolizumab/Enfortumab Vedotin in Muscle Invasive Bladder Cancer

Radiation ± Chemotherapy Shows Worse Short-Term QOL in Cervical Cancer

Personalized Medicine and Targeted Therapy May Hold Promise in Lung Cancer

Fertility-Sparing Surgery May Be Safe Despite Recurrence in Cervical Cancer

© 2025 MJH Life Sciences^®

All rights reserved.